Last updated: May 3, 2023
Sponsor: Wake Forest University Health Sciences
Overall Status: Completed
Phase
N/A
Condition
Amyotrophic Lateral Sclerosis (Als)
Scar Tissue
Myasthenia Gravis (Chronic Weakness)
Treatment
Virtual Seating Coach
Clinical Study ID
NCT05742828
IRB00082646
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Treatment group:
- Inclusion will be diagnosis of amyotrophic lateral sclerosis (ALS)
- Current clinic client at The Carolinas Neuromuscular ALS/MDA Center'sMultidisciplinary ALS clinic
- Currently using a Permobil power wheelchair with power seating with R-Net electronicsthat accepts the VSC
- Has a Permobil Corpus 3G (6 months old or newer) or who order a new Permobil powerwheelchair.
- New Permobil chairs which are not obtained through this clinic will also be able toenter the study, such as chairs from other regions or from the Veteran'sAdministration. Comparison group:
- Inclusion will be diagnosis of ALS
- Current clinic client at The Carolinas Neuromuscular ALS/Muscular DystrophyAssociation (MDA) Center's multidisciplinary ALS clinic
- Currently using a power wheelchair with power seating.
- New chairs which are not obtained through this clinic will also be able to enter thestudy, such as chairs from other regions or from the Veteran's Administration.
Exclusion
Exclusion Criteria: Treatment group:
- Another diagnosis besides ALS
- Does not have a Smart phone or tablet
- Frontotemporal Dementia as noted by MD/SLP/SW (Medical Doctor/Speech LanguagePathologist/Social Worker) in medical records
- Inability/unwillingness to control wheelchair power features (client)
- Unwillingness to be monitored by study staff and alerted by VSC over time
- Uses other mobility devices indoors (scooter, basic power wheelchair) more than or inaddition to Permobil PWC Comparison group:
- Another diagnosis besides ALS
- Frontotemporal Dementia as noted by MD/SLP/SW in medical records
- Inability/unwillingness to control wheelchair power features (client)
- Unwillingness to be monitored by study staff
- Uses other mobility devices indoors (scooter, basic power wheelchair) more than or inaddition to power wheelchair
- Further exclusions may be added in future protocol versions
Study Design
Total Participants: 39
Treatment Group(s): 1
Primary Treatment: Virtual Seating Coach
Phase:
Study Start date:
September 20, 2017
Estimated Completion Date:
March 31, 2020
Study Description
Connect with a study center
Atrium Health - Neurosciences Institute
Charlotte, North Carolina 28207
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.